OptimizeRx Corp reports results for the quarter ended December 31 - Earnings Summary

• OptimizeRx Corp OPRX.OQ reported quarterly adjusted earnings of 30 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of 26 cents. The mean expectation of eight analysts for the quarter was for earnings of 27 cents per share. Wall Street expected results to range from 23 cents to 31 cents per share.

• Revenue rose 13.9% to $32.32 million from a year ago; analysts expected $30.36 million.

• OptimizeRx Corp's reported EPS for the quarter was breakeven results​.

• The company reported a quarterly loss of $77 thousand.

• OptimizeRx Corp shares had fallen by 14.8% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 9.8% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the online services peer group is also "buy"

Wall Street's median 12-month price target for OptimizeRx Corp is $8.00

This summary was machine generated from LSEG data March 12 at 01:30 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)